Regenerative Medical Technology Group Inc.

OTCPK:RMTG Stock Report

Market Cap: US$470.2k

Regenerative Medical Technology Group Past Earnings Performance

Past criteria checks 0/6

Regenerative Medical Technology Group's earnings have been declining at an average annual rate of -13%, while the Specialty Retail industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 63% per year.

Key information

-13.0%

Earnings growth rate

-0.9%

EPS growth rate

Specialty Retail Industry Growth26.6%
Revenue growth rate63.0%
Return on equityn/a
Net Margin-161.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Regenerative Medical Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:RMTG Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243-520
30 Jun 243-1020
31 Mar 242-1020
31 Dec 232-1020
30 Sep 232-1120
30 Jun 232-620
31 Mar 232-620
31 Dec 222-620
30 Sep 221-620
30 Jun 221-15110
31 Mar 221-14100
31 Dec 210-13100
30 Sep 210-6100
30 Jun 210-310
31 Mar 210-610
31 Dec 200-600
30 Sep 200-1320
30 Jun 200-720
31 Mar 200-120
31 Dec 190-320
30 Sep 190-300
30 Jun 190-200
31 Mar 190-500
31 Dec 180-200
30 Sep 180-100
31 Dec 170000
31 Dec 160-400
31 Dec 150-210

Quality Earnings: RMTG is currently unprofitable.

Growing Profit Margin: RMTG is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RMTG is unprofitable, and losses have increased over the past 5 years at a rate of 13% per year.

Accelerating Growth: Unable to compare RMTG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RMTG is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-4.8%).


Return on Equity

High ROE: RMTG's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:42
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Regenerative Medical Technology Group Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution